178 related articles for article (PubMed ID: 24124520)
1. Ouabain, a cardiac glycoside, inhibits the Fanconi anemia/BRCA pathway activated by DNA interstrand cross-linking agents.
Jun DW; Hwang M; Kim HJ; Hwang SK; Kim S; Lee CH
PLoS One; 2013; 8(10):e75905. PubMed ID: 24124520
[TBL] [Abstract][Full Text] [Related]
2. CRL4 ubiquitin ligase stimulates Fanconi anemia pathway-induced single-stranded DNA-RPA signaling.
Codilupi T; Taube D; Naegeli H
BMC Cancer; 2019 Nov; 19(1):1042. PubMed ID: 31690264
[TBL] [Abstract][Full Text] [Related]
3. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.
Guervilly JH; Macé-Aimé G; Rosselli F
Hum Mol Genet; 2008 Mar; 17(5):679-89. PubMed ID: 18029388
[TBL] [Abstract][Full Text] [Related]
4. Arsenic exposure disrupts the normal function of the FA/BRCA repair pathway.
Peremartí J; Ramos F; Marcos R; Hernández A
Toxicol Sci; 2014 Nov; 142(1):93-104. PubMed ID: 25092648
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor.
Rego MA; Harney JA; Mauro M; Shen M; Howlett NG
Oncogene; 2012 Jan; 31(3):366-75. PubMed ID: 21685936
[TBL] [Abstract][Full Text] [Related]
6. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
Chen P; Li J; Jiang HG; Lan T; Chen YC
Tumour Biol; 2015 May; 36(5):3591-9. PubMed ID: 25542235
[TBL] [Abstract][Full Text] [Related]
7. AMP-activated protein kinase is involved in the activation of the Fanconi anemia/BRCA pathway in response to DNA interstrand crosslinks.
Chun MJ; Kim S; Hwang SK; Kim BS; Kim HG; Choi HI; Kim JH; Goh SH; Lee CH
Oncotarget; 2016 Aug; 7(33):53642-53653. PubMed ID: 27449087
[TBL] [Abstract][Full Text] [Related]
8. Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network.
Bick G; Zhang F; Meetei AR; Andreassen PR
Chromosoma; 2017 Jun; 126(3):417-430. PubMed ID: 27277787
[TBL] [Abstract][Full Text] [Related]
9. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway.
Rothfuss A; Grompe M
Mol Cell Biol; 2004 Jan; 24(1):123-34. PubMed ID: 14673148
[TBL] [Abstract][Full Text] [Related]
10. Aurora A kinase is required for activation of the Fanconi anemia/BRCA pathway upon DNA damage.
Chun MJ; Hwang SK; Kim HG; Goh SH; Kim S; Lee CH
FEBS Open Bio; 2016 Jul; 6(7):782-90. PubMed ID: 27398318
[TBL] [Abstract][Full Text] [Related]
11. Snm1B/Apollo functions in the Fanconi anemia pathway in response to DNA interstrand crosslinks.
Mason JM; Sekiguchi JM
Hum Mol Genet; 2011 Jul; 20(13):2549-59. PubMed ID: 21478198
[TBL] [Abstract][Full Text] [Related]
12. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.
Wang X; Kennedy RD; Ray K; Stuckert P; Ellenberger T; D'Andrea AD
Mol Cell Biol; 2007 Apr; 27(8):3098-108. PubMed ID: 17296736
[TBL] [Abstract][Full Text] [Related]
13. The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells.
Yao C; Du W; Chen H; Xiao S; Huang L; Chen F
Leuk Lymphoma; 2015 Mar; 56(3):755-62. PubMed ID: 24996439
[TBL] [Abstract][Full Text] [Related]
14. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.
Kim H; D'Andrea AD
Genes Dev; 2012 Jul; 26(13):1393-408. PubMed ID: 22751496
[TBL] [Abstract][Full Text] [Related]
15. The Fanconi anemia ID2 complex: dueling saxes at the crossroads.
Boisvert RA; Howlett NG
Cell Cycle; 2014; 13(19):2999-3015. PubMed ID: 25486561
[TBL] [Abstract][Full Text] [Related]
16. A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway.
Landais I; Sobeck A; Stone S; LaChapelle A; Hoatlin ME
Int J Cancer; 2009 Feb; 124(4):783-92. PubMed ID: 19048618
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway.
Chirnomas D; Taniguchi T; de la Vega M; Vaidya AP; Vasserman M; Hartman AR; Kennedy R; Foster R; Mahoney J; Seiden MV; D'Andrea AD
Mol Cancer Ther; 2006 Apr; 5(4):952-61. PubMed ID: 16648566
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair.
Li N; Wang J; Wallace SS; Chen J; Zhou J; D'Andrea AD
Nucleic Acids Res; 2020 Apr; 48(6):3014-3028. PubMed ID: 31980815
[TBL] [Abstract][Full Text] [Related]
19. Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors.
Landais I; Hiddingh S; McCarroll M; Yang C; Sun A; Turker MS; Snyder JP; Hoatlin ME
Mol Cancer; 2009 Dec; 8():133. PubMed ID: 20043851
[TBL] [Abstract][Full Text] [Related]
20. A Boolean network model of the FA/BRCA pathway.
Rodríguez A; Sosa D; Torres L; Molina B; Frías S; Mendoza L
Bioinformatics; 2012 Mar; 28(6):858-66. PubMed ID: 22267503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
